Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients
Status:
Recruiting
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
A randomized, double blind, placebo-controlled, phase 2 clinical trial to investigate the
efficacy and safety of 2 doses of NuSepin® intravenous infusion in COVID-19 pneumonia
patients